Bottom Line: Sweet success
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.CRISIS, what crisis? Cadbury Schweppes may warn that pressure from food retailers is relentless, but the company is still gliding impressively onwards.
Price pressure there undoubtedly is, but Cadbury is adept at dealing with it. In Britain, which still accounts for 46 per cent of its business, drinks prices fell 3 per cent as customers traded down to cheaper brands and up to larger sizes and multipacks. Confectionery prices rose 1 per cent but the price of sugar increased by 13 per cent. Yet it still managed to push underlying profits ahead by 7.2 per cent on sales up 3 per cent.
That reflects further strides in efficiency - sales per employee rose 4.6 per cent but their equivalent costs only 1.6 per cent - keeping margins on their upward trend. While there must surely be a limit to the scope for margin improvement, Cadbury shows no signs of having reached it yet.
The healthy margins also keep cash flowing into the business - pounds 185m last year, up from pounds 100m, before the acquisitions and rights issues. That is just as well, given its acquisition ambitions, unsated even after pounds 476m spent last year.
The nagging worry that it will top even that level of spending with a full bid for Dr Pepper- Seven-Up - requiring a further rights issue - is one of the only dampeners on its shares. But, with a further 14 per cent growth expected this year, putting the shares on a market multiple of 15, there is enough value in them for that to be a minor concern.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments